Insider · CIK 0002029477
Henry E. Pelish
Files at NUVL (Nuvalent, Inc.). First filing Jun 10, 2025, latest Mar 16, 2026.
Henry E. Pelish files SEC Form 4 as officer at NUVL (Nuvalent, Inc.). Since Jun 10, 2025, Henry E. Pelish has reported 0 open-market buys worth $0 and 9 open-market sells worth $8.3M, the latest filed on Mar 16, 2026.
A track record needs three past buys with six months of prices behind them; Henry E. Pelish has 0, so none is measured yet.
The newest scored trade: sold $3.4M of NUVL on Mar 12, 2026, filed Mar 16, 2026, scored 30 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 4 sells worth $6.1M.
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Nuvalent, Inc. | $3.4M 35,104 shares | -35% | - | |
| 28Weak | Nuvalent, Inc. | $502k 5,160 shares | -7% | - | |
| 25Weak | Nuvalent, Inc. | $1.3M 14,205 shares | -18% | - | |
| 24Weak | Nuvalent, Inc. | $895k 10,070 shares | -14% | - | |
| 2Weak | Nuvalent, Inc. | $294k 3,725 shares | -5% | - | |
| 11Weak | Nuvalent, Inc. | $412k 5,500 shares | -8% | - | |
| 20Weak | Nuvalent, Inc. | $614k 7,645 shares | -12% | - | |
| 23Weak | Nuvalent, Inc. | $863k 10,800 shares | -15% | - | |
| 0Weak | Nuvalent, Inc. | $16k 200 shares | -0% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 6, 2025 | NUVL NUVALENT INC | 22,000 0.03% of outstanding | $1.7M | Jun 6, 2025 | none |
| Jan 6, 2025 | NUVL Nuvalent, Inc. | 2,750 0.00% of outstanding | $222k | Jan 6, 2025 | none |
Transactions
The newest 50 of 95 rows this insider has filed.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 12, 2026 | NUVL Nuvalent, Inc. | MOption exercise Class A Common Stock10b5-1 | +8,456 | $18.93 | $160k | 91,844 | Mar 16, 2026 |
| Mar 12, 2026 | NUVL Nuvalent, Inc. | MOption exercise Class A Common Stock10b5-1 | +1,754 | $27.85 | $49k | 93,598 | Mar 16, 2026 |
| Mar 12, 2026 | NUVL Nuvalent, Inc. | MOption exercise Class A Common Stock10b5-1 | +4,125 | $29.33 | $121k | 97,723 | Mar 16, 2026 |
| Mar 12, 2026 | NUVL Nuvalent, Inc. | MOption exercise Class A Common Stock10b5-1 | +2,985 | $72.35 | $216k | 100,708 | Mar 16, 2026 |
| Mar 12, 2026 | NUVL Nuvalent, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -24,189 | $97.79 | $2.4M | 76,519 | Mar 16, 2026 |
| Mar 12, 2026 | NUVL Nuvalent, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -5,505 | $98.44 | $542k | 71,014 | Mar 16, 2026 |
| Mar 12, 2026 | NUVL Nuvalent, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -306 | $99.12 | $30k | 70,708 | Mar 16, 2026 |
| Mar 13, 2026 | NUVL Nuvalent, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -804 | $97.89 | $79k | 69,904 | Mar 16, 2026 |
| Mar 13, 2026 | NUVL Nuvalent, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -2,597 | $98.83 | $257k | 67,307 | Mar 16, 2026 |
| Mar 13, 2026 | NUVL Nuvalent, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -1,703 | $99.71 | $170k | 65,604 | Mar 16, 2026 |
| Mar 12, 2026 | NUVL Nuvalent, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -8,456 | $0.00 | $0 | 2,113 | Mar 16, 2026 |
| Mar 12, 2026 | NUVL Nuvalent, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,754 | $0.00 | $0 | 11,402 | Mar 16, 2026 |
| Mar 12, 2026 | NUVL Nuvalent, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -4,125 | $0.00 | $0 | 9,900 | Mar 16, 2026 |
| Mar 12, 2026 | NUVL Nuvalent, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -2,985 | $0.00 | $0 | 21,073 | Mar 16, 2026 |
| Jan 5, 2026 | NUVL Nuvalent, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -513 | $96.06 | $49k | 70,535 | Jan 7, 2026 |
| Jan 5, 2026 | NUVL Nuvalent, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -660 | $96.85 | $64k | 69,875 | Jan 7, 2026 |
| Jan 5, 2026 | NUVL Nuvalent, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -1,137 | $97.96 | $111k | 68,738 | Jan 7, 2026 |
| Jan 5, 2026 | NUVL Nuvalent, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -186 | $98.52 | $18k | 68,552 | Jan 7, 2026 |
| Jan 6, 2026 | NUVL Nuvalent, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -1,106 | $96.75 | $107k | 67,446 | Jan 7, 2026 |
| Jan 6, 2026 | NUVL Nuvalent, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -1,369 | $97.33 | $133k | 66,077 | Jan 7, 2026 |
| Jan 6, 2026 | NUVL Nuvalent, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -189 | $98.40 | $19k | 65,888 | Jan 7, 2026 |
| Jan 7, 2026 | NUVL Nuvalent, Inc. | AGrant or award Class A Common Stock10b5-1 | +17,500 | $0.00 | $0 | 83,388 | Jan 7, 2026 |
| Jan 7, 2026 | NUVL Nuvalent, Inc. | AGrant or award Stock Option (Right to Buy)derivative10b5-1 | +17,500 | $0.00 | $0 | 17,500 | Jan 7, 2026 |
| Dec 22, 2025 | NUVL Nuvalent, Inc. | MOption exercise Class A Common Stock | +5,085 | $1.08 | $5,492 | 71,048 | Dec 23, 2025 |
| Dec 22, 2025 | NUVL Nuvalent, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -5,085 | $0.00 | $0 | 0 | Dec 23, 2025 |
| Oct 15, 2025 | NUVL Nuvalent, Inc. | MOption exercise Class A Common Stock10b5-1 | +3,668 | $18.93 | $69k | 69,631 | Oct 17, 2025 |
| Oct 15, 2025 | NUVL Nuvalent, Inc. | MOption exercise Class A Common Stock10b5-1 | +7,495 | $27.85 | $209k | 77,126 | Oct 17, 2025 |
| Oct 15, 2025 | NUVL Nuvalent, Inc. | MOption exercise Class A Common Stock10b5-1 | +3,042 | $72.35 | $220k | 80,168 | Oct 17, 2025 |
| Oct 15, 2025 | NUVL Nuvalent, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -14,205 | $90.04 | $1.3M | 65,963 | Oct 17, 2025 |
| Oct 15, 2025 | NUVL Nuvalent, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -3,668 | $0.00 | $0 | 10,569 | Oct 17, 2025 |
| Oct 15, 2025 | NUVL Nuvalent, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -7,495 | $0.00 | $0 | 13,156 | Oct 17, 2025 |
| Oct 15, 2025 | NUVL Nuvalent, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -3,042 | $0.00 | $0 | 24,058 | Oct 17, 2025 |
| Oct 13, 2025 | NUVL Nuvalent, Inc. | MOption exercise Class A Common Stock10b5-1 | +1,669 | $18.93 | $32k | 67,632 | Oct 15, 2025 |
| Oct 13, 2025 | NUVL Nuvalent, Inc. | MOption exercise Class A Common Stock10b5-1 | +4,168 | $27.85 | $116k | 71,800 | Oct 15, 2025 |
| Oct 13, 2025 | NUVL Nuvalent, Inc. | MOption exercise Class A Common Stock10b5-1 | +1,800 | $72.35 | $130k | 73,600 | Oct 15, 2025 |
| Oct 13, 2025 | NUVL Nuvalent, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -7,637 | $89.81 | $686k | 65,963 | Oct 15, 2025 |
| Oct 14, 2025 | NUVL Nuvalent, Inc. | MOption exercise Class A Common Stock10b5-1 | +731 | $18.93 | $14k | 66,694 | Oct 15, 2025 |
| Oct 14, 2025 | NUVL Nuvalent, Inc. | MOption exercise Class A Common Stock10b5-1 | +877 | $27.85 | $24k | 67,571 | Oct 15, 2025 |
| Oct 14, 2025 | NUVL Nuvalent, Inc. | MOption exercise Class A Common Stock10b5-1 | +825 | $29.33 | $24k | 68,396 | Oct 15, 2025 |
| Oct 14, 2025 | NUVL Nuvalent, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -1,167 | $84.98 | $99k | 67,229 | Oct 15, 2025 |
| Oct 14, 2025 | NUVL Nuvalent, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -866 | $86.11 | $75k | 66,363 | Oct 15, 2025 |
| Oct 14, 2025 | NUVL Nuvalent, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -400 | $87.39 | $35k | 65,963 | Oct 15, 2025 |
| Oct 13, 2025 | NUVL Nuvalent, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,669 | $0.00 | $0 | 14,968 | Oct 15, 2025 |
| Oct 13, 2025 | NUVL Nuvalent, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -4,168 | $0.00 | $0 | 21,528 | Oct 15, 2025 |
| Oct 13, 2025 | NUVL Nuvalent, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,800 | $0.00 | $0 | 27,100 | Oct 15, 2025 |
| Oct 14, 2025 | NUVL Nuvalent, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -731 | $0.00 | $0 | 14,237 | Oct 15, 2025 |
| Oct 14, 2025 | NUVL Nuvalent, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -877 | $0.00 | $0 | 20,651 | Oct 15, 2025 |
| Oct 14, 2025 | NUVL Nuvalent, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -825 | $0.00 | $0 | 14,025 | Oct 15, 2025 |
| Sep 10, 2025 | NUVL Nuvalent, Inc. | MOption exercise Class A Common Stock10b5-1 | +731 | $18.93 | $14k | 66,694 | Sep 12, 2025 |
| Sep 10, 2025 | NUVL Nuvalent, Inc. | MOption exercise Class A Common Stock10b5-1 | +877 | $27.85 | $24k | 67,571 | Sep 12, 2025 |
Questions about Henry E. Pelish
Answered from the filings on this page, as of the latest one.
Is Henry E. Pelish buying or selling?
In the last 12 months Henry E. Pelish reported 0 open-market buys worth $0 and 4 open-market sells worth $6.1M on SEC Form 4; the latest was sold $3.4M of NUVL on Mar 12, 2026. Grants, option exercises and tax withholding are not counted.
How did Henry E. Pelish's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Henry E. Pelish has 0.
Where does Henry E. Pelish file Form 4?
Henry E. Pelish has filed Form 4 at NUVL (Nuvalent, Inc.) as Chief Scientific Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.